FDA Approved: SCOPOLAMINE TRANSDERMAL SYSTEM — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a supplemental application for Scopolamine Transdermal System submitted by Padagis Israel Pharmaceuticals Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motion Sickness
• Postoperative Nausea and Vomiting

Drugs mentioned

• SCOPOLAMINE TRANSDERMAL SYSTEM (scopolamine transdermal system)

Snippet

SUPPL AP for SCOPOLAMINE TRANSDERMAL SYSTEM (SCOPOLAMINE TRANSDERMAL SYSTEM)